Page 109 - AN-4-1
P. 109

Advanced Neurology                                                       TDP-43 regulates IFN1 production



            Supervision: Wenjuan Zhang, Daihe Yang, Guohua Song     doi: 10.1007/s00401-008-0402-2
            Validation: Wenjuan Zhang, Cao Huang               8.   Bose JK, Huang CC, James Shen CK. Regulation of
            Visualization: Zhen Yi, Yifan Hao, Feng Zhou          autophagy by neuropathological protein TDP-43.  J  Biol
            Writing – original draft: Cao Huang, Bo Huang         Chem. 2011;286(52):44441-44448.
            Writing – review & editing: Zhen Yi, Yifan Hao, Cao Huang,      doi: 10.1074/jbc.M111.237115
               Yun Zhou, Bo Huang
                                                               9.   Foster AD, Downing P, Figredo E, et al. ALS-associated TBK1
            Ethics approval and consent to participate            variant p.G175S is defective in phosphorylation of p62 and
                                                                  impacts TBK1-mediated signalling and TDP-43 autophagic
            Not applicable.                                       degradation. Mol Cell Neurosci. 2020;108:103539.
            Consent for publication                               doi: 10.1016/j.mcn.2020.103539

            Not applicable.                                    10.  Deng HX, Chen W, Hong ST, et al. Mutations in UBQLN2
                                                                  cause dominant X-linked juvenile and adult-onset ALS and
            Availability of data                                  ALS/dementia. Nature. 2011;477(7363):211-215.

            All data are available from the co-authors on reasonable      doi: 10.1038/nature10353
            request.                                           11.  Murray ME, DeJesus-Hernandez M, Rutherford NJ,  et al.
                                                                  Clinical  and  neuropathologic  heterogeneity  of  c9FTD/
            References                                            ALS associated with hexanucleotide repeat expansion in
                                                                  C9ORF72. Acta Neuropathol. 2011;122(6):673-690.
            1.   Weskamp K, Tank EM, Miguez R, et al. Shortened TDP
                                                         43
               isoforms upregulated by neuronal hyperactivity drive TDP       doi: 10.1007/s00401-011-0907-y
                                                         43
               pathology in ALS. J Clin Invest. 2020;130(3):1139-1155.  12.  Smith BN, Vance C, Scotter EL,  et al. Novel mutations
               doi: 10.1172/JCI130988                             support a role for profilin 1 in the pathogenesis of ALS.
                                                                  Neurobiol Aging. 2015;36(3):1602.e17-e27.
            2.   Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK.
               Molecular mechanisms of TDP-43 misfolding and pathology      doi: 10.1016/j.neurobiolaging.2014.10.032
               in amyotrophic lateral sclerosis.  Front Mol Neurosci.   13.  Oakes JA, Davies MC, Collins MO. TBK1: A new player in
               2019;12:25.                                        ALS linking autophagy and neuroinflammation. Mol Brain.
               doi: 10.3389/fnmol.2019.00025                      2017;10(1):5.
            3.   Polymenidou M, Lagier-Tourenne C, Hutt KR, et al. Long      doi: 10.1186/s13041-017-0287-x
               pre-mRNA depletion and RNA missplicing contribute to   14.  Marchlik E, Thakker P, Carlson T, et al. Mice lacking Tbk1
               neuronal vulnerability from loss of TDP-43. Nat Neurosci.   activity exhibit immune cell infiltrates in multiple tissues
               2011;14(4):459-468.                                and increased susceptibility to LPS-induced lethality.
               doi: 10.1038/nn.2779                               J Leukoc Biol. 2010;88(6):1171-1180.
            4.   Liu G, Coyne AN, Pei F, et al. Endocytosis regulates TDP-43      doi: 10.1189/jlb.0210071
               toxicity and turnover. Nat Commun. 2017;8(1):2092.  15.  Chen T, Zhang W, Huang B, Chen X, Huang C. UBQLN2
               doi: 10.1038/s41467-017-02017-x                    promotes the production of type I interferon via the TBK1-
                                                                  IRF3 pathway. Cells. 2020;9(5):1205.
            5.   Xia  Q,  Wang  H,  Hao  Z,  et al.  TDP-43  loss  of  function
               increases TFEB activity and blocks autophagosome-     doi: 10.3390/cells9051205
               lysosome fusion. EMBO J. 2016;35(2):121-142.    16.  Liu YJ. IPC: Professional type 1 interferon-producing cells
               doi: 10.15252/embj.201591998                       and plasmacytoid dendritic cell precursors.  Annu Rev
                                                                  Immunol. 2005;23:275-306.
            6.   Wang W, Wang L, Lu J,  et al. The inhibition of TDP-43
               mitochondrial localization blocks its neuronal toxicity. Nat      doi: 10.1146/annurev.immunol.23.021704.115633
               Med. 2016;22(8):869-878.                        17.  Honda K, Yanai H, Negishi H,  et al. IRF-7 is the master
                                                                  regulator of type-I interferon-dependent immune responses.
               doi: 10.1038/nm.4130
                                                                  Nature. 2005;434(7034):772-777.
            7.   Hiji M, Takahashi T, Fukuba H, Yamashita H, Kohriyama T,
               Matsumoto M. White matter lesions in the brain with      doi: 10.1038/nature03464
               frontotemporal lobar degeneration with motor neuron disease:   18.  Wang J, Yang B, Hu Y, et al. Negative regulation of Nmi on
               TDP-43-immunopositive inclusions co-localize with p62, but   virus-triggered type  I IFN production by targeting IRF7.
               not ubiquitin. Acta Neuropathol. 2008;116(2):183-191.  J Immunol. 2013;191(6):3393-3399.



            Volume 4 Issue 1 (2025)                        103                               doi: 10.36922/an.6272
   104   105   106   107   108   109   110   111   112   113   114